Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

270
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

97
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

INVESTIGATION ON SERUM LEVELS OF INTERLEUKIN-18 AND INTERLEUKIN-6 IN PATIENTS WITH DERMATOMYOSITIS AND POLYMYOSITIS

Pages

  0-0

Abstract

 Background: DERMATOMYOSITIS (DM) and POLYMYOSITIS (PM) are common forms of idiopathic inflammatory myopathy which are characterized by muscle inflammation with an unknown cause. Immune cells infiltrate myofibrils and endomysial capillaries, which leads to damage of muscle fibers through the production of humoral factors and different cytokines.Objectives: Increased IL-18 and IL-6 serum levels have been reported in a variety of autoimmune diseases, including rheumatoid arthritis and inflammatory bowel disease. The purpose of this study was to evaluate IL-18 and IL-6 serum levels inDMandPMpatients compared to a healthy control group.Patients and Methods: In this cross-sectional study, 15 patients with DM, 5 patients with PM, and 20 healthy control subjects were recruited. Thelevels of serumIL-18andIL-6 in patientsandcontrol groupsweremeasuredbyusing ELISA assay. Blood testsweretaken to determine the levels of C-reactive protein (CRP) and creatine kinase (CK) and were measured by standard methods. Statistical analyses were performed using the Mann-Whitney U-test with a non-Gaussian population using SPSS 19 software.Results: IL-18 levels were significantly higher inDMpatients andPMpatients before treatment compared to healthy control subjects (P=0.001, P=0.01, respectively). There were no significant differences between DM and PM patients before treatment with healthy controls for IL-6 serum levels (P=0.51, P=0.43, respectively).Conclusions: Serum IL-18 contributes to the immunopathogenesis of DM and PM and would be a useful marker for the diagnosis and treatment of diseases. IL-6 has a less pivotal role in the pathology of DM and PM.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    KHAZAEI ASL, SAMANEH, SHAHRAKI, ALI, & ZAKERI, ZAHRA. (2016). INVESTIGATION ON SERUM LEVELS OF INTERLEUKIN-18 AND INTERLEUKIN-6 IN PATIENTS WITH DERMATOMYOSITIS AND POLYMYOSITIS. SHIRAZ E MEDICAL JOURNAL, 17(2), 0-0. SID. https://sid.ir/paper/299641/en

    Vancouver: Copy

    KHAZAEI ASL SAMANEH, SHAHRAKI ALI, ZAKERI ZAHRA. INVESTIGATION ON SERUM LEVELS OF INTERLEUKIN-18 AND INTERLEUKIN-6 IN PATIENTS WITH DERMATOMYOSITIS AND POLYMYOSITIS. SHIRAZ E MEDICAL JOURNAL[Internet]. 2016;17(2):0-0. Available from: https://sid.ir/paper/299641/en

    IEEE: Copy

    SAMANEH KHAZAEI ASL, ALI SHAHRAKI, and ZAHRA ZAKERI, “INVESTIGATION ON SERUM LEVELS OF INTERLEUKIN-18 AND INTERLEUKIN-6 IN PATIENTS WITH DERMATOMYOSITIS AND POLYMYOSITIS,” SHIRAZ E MEDICAL JOURNAL, vol. 17, no. 2, pp. 0–0, 2016, [Online]. Available: https://sid.ir/paper/299641/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top